"AIDS-Related Complex" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS.
| Descriptor ID |
D000386
|
| MeSH Number(s) |
C02.782.815.616.400.080 C02.800.801.400.080 C02.839.080 C20.673.480.080
|
| Concept/Terms |
AIDS-Related Complex- AIDS-Related Complex
- AIDS Related Complex
- Complex, AIDS-Related
- Lymphadenopathy Syndrome
- Lymphadenopathy Syndromes
- Syndrome, Lymphadenopathy
- Syndromes, Lymphadenopathy
- ARC
|
Below are MeSH descriptors whose meaning is more general than "AIDS-Related Complex".
Below are MeSH descriptors whose meaning is more specific than "AIDS-Related Complex".
This graph shows the total number of publications written about "AIDS-Related Complex" by people in this website by year, and whether "AIDS-Related Complex" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "AIDS-Related Complex" by people in Profiles.
-
Horton CM, Dudley MN, Kaul S, Mayer KH, Squires K, Dunkle L, Anderson R. Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex. Antimicrob Agents Chemother. 1995 Oct; 39(10):2309-15.
-
Murray HW, Squires KE, Weiss W, Sledz S, Sacks HS, Hassett J, Cross A, Anderson RE, Dunkle LM. Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089. J Infect Dis. 1995 Mar; 171 Suppl 2:S123-30.
-
Tenner-Racz K, Brachtel E, Racz P. [Histologic classification of HIV-1 induced lymphadenopathy. Current results on the pathogenesis of germinal center changes]. Verh Dtsch Ges Pathol. 1991; 75:69-79.
-
Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 1990 Apr 19; 322(16):1098-105.
-
McKinney RE, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC, et al. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group. J Pediatr. 1990 Apr; 116(4):640-7.
-
Dubinsky RM, Yarchoan R, Dalakas M, Broder S. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC). Muscle Nerve. 1989 Oct; 12(10):856-60.
-
Cockerell CJ, Whitlow MA, Webster GF, Friedman-Kien AE. Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet. 1987 Sep 19; 2(8560):654-6.
-
Flomenberg PR, Chen M, Munk G, Horwitz MS. Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts. J Infect Dis. 1987 Jun; 155(6):1127-34.
-
Polan HJ, Amchin J. Treating AIDS patients. Hosp Community Psychiatry. 1987 May; 38(5):531-2.
-
Amchin J, Polan HJ. A longitudinal account of staff adaptation to AIDS patients on a psychiatric unit. Hosp Community Psychiatry. 1986 Dec; 37(12):1235-8.